Credit Suisse Ag Seagen Inc. Transaction History

Credit Suisse Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $1.29 Million - $1.45 Million	6,726 Added 3.16%	219,774 $46.6 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $8.11 Million - $8.92 Million	-43,225 Reduced 16.87%	213,048 $41 Million
Q1 2023 May 10, 2023	BUY	$127.59 - $203.08 $6.42 Million - $10.2 Million	50,290 Added 24.41%	256,273 $51.9 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $2.4 Million - $2.84 Million	20,414 Added 11.0%	205,983 $26.5 Million
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $3.44 Million - $4.58 Million	-25,452 Reduced 12.06%	185,569 $25.4 Million

Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $1.53 Million - $2.51 Million	-14,021 Reduced 6.23%	211,021 $37.3 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $60,403 - $79,714	505 Added 0.22%	225,042 $32.4 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $4.26 Million - $5.7 Million	29,876 Added 15.35%	224,537 $34.7 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $2.11 Million - $2.51 Million	14,782 Added 8.22%	194,661 $33.1 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $337,294 - $402,266	-2,497 Reduced 1.37%	179,879 $28.4 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $4.76 Million - $6.61 Million	-34,632 Reduced 15.96%	182,376 $25.3 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $35.7 Million - $46 Million	217,008 New	217,008 $38 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.